Exact Sciences is a pioneering brand that is revolutionizing cancer detection with its multi-cancer early detection (MCED) tests. These tests offer a fundamentally new approach to screening and detecting various types of cancers. With a single blood draw, the MCED tests enable the screening of multiple cancer types, including those without recommended screening methods.

By combining MCED tests with standard-of-care screenings, such as mammograms and colon cancer screenings, Exact Sciences aims to transform early cancer detection. The development goals of Exact Sciences include designing a multi-biomarker class and machine-learning approach to enable earlier cancer detection, detecting cancers in multiple organs, delivering high early-stage sensitivity, and providing high specificity in detecting cancer. The brand brings decades of expertise to MCED testing, building on its success with products like Cologuard® and Oncotype DX®.

It is dedicated to developing an MCED test based on CancerSEEK technology, which has shown promising results in large-scale studies. By offering a simple and minimally invasive blood collection method, Exact Sciences aims to bring early detection and a greater range of cancer screenings to more patients than ever before. With their comprehensive scientific expertise and commitment to innovation, Exact Sciences is at the forefront of advancing cancer screening and improving patient outcomes